Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis

The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of abatacept for cGvHD therapy in a retrospective study with 15 patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Wertheimer, Tobias, Dohse, Marius, Afram, Gabriel, Weber, Daniela, Heidenreich, Martin, Holler, Barbara, Kattner, Anna-Sophia, Neubauer, Andreas, Mielke, Stephan, Ljungman, Per, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Martínez, Antonio Pérez, Fante, Matthias, Wolff, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914235/
https://www.ncbi.nlm.nih.gov/pubmed/33515310
http://dx.doi.org/10.1007/s00277-021-04434-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914235/
https://www.ncbi.nlm.nih.gov/pubmed/33515310
http://dx.doi.org/10.1007/s00277-021-04434-x

Ejemplares similares